Analyst Research

Report Title Price
Provider: New Constructs, LLC
Provider: Thomson Reuters Stock Report
Provider: MacroRisk Analytics/EconomicInvestor
Provider: S&P Capital IQ Quantitative Report

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

GenVec Inc Announces Management Change-Form 8-K

Thursday, 5 Sep 2013 04:43pm EDT 

GenVec Inc reported in its Form 8-K that on September 3, 2013, Cynthia Collins, the Company’s President, Chief Executive Officer (CEO) and Principal Executive Officer departed the Company and resigned from the Company’s Board of Directors effective immediately. On September 3, 2013, the Company’s Board of Directors appointed Douglas J. Swirsky, as the President and Chief Executive Officer (CEO) of the Company effective immediately. The Board of Directors also appointed Mr. Swirsky as a member of the Company’s Board of Directors effective immediately. 

Company Quote

29 Jul 2014